Aflibercept (2.0 mg)

Drug identity checked against registry records

Also recorded as Eylea

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTONCT07734844KODPhase 3Recruiting2028-08-31Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.